Effect of neoadjuvant chemoradiotherapy (nCRT) on survival in patients with borderline resectable (BR) pancreatic adenocarcinoma (PDA) with acceptable peri-operative morbidity.
Rebecca Manget Minter
No relevant relationships to disclose
Mary Uan-Sian Feng
No relevant relationships to disclose
Mahmoud Al-Hawary
No relevant relationships to disclose
Jincheng Shen
No relevant relationships to disclose
Matthew J Schipper
No relevant relationships to disclose
Filip Bednar
No relevant relationships to disclose
Erica Proctor
No relevant relationships to disclose
Susanne Gray Warner
No relevant relationships to disclose
Mark M. Zalupski
No relevant relationships to disclose
Diane M. Simeone
No relevant relationships to disclose